Liesap SRL
Liesap reported total assets of 72,120 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Liesap shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -52 % Total assets +60 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Liesap's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
Liesap's financial analysis
- Solvency23.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Liesap
Liesap's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0776.459.858
- VAT number
- BE0776459858
- Peppol
- Registered · 0208:0776459858 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Oct 2021
- Registered office
- 9260 Wichelen
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Liesap (SRL) has been based in Wichelen since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 6,704 € and equity of 16,616 €; its revenue is not published. Its solvency stands at 23.0%, below the median of its sector (44.2%).
Companies similar to Liesap
Companies in the same business, of comparable size and area, outside its group.
- A.Catrin Pharma Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 94,339 €
- Antoine Derbaud Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 126,424 €
- Kephas Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 57,577 €
- Quantum Satis Retail sale of pharmaceutical products Zele · balance sheet 34,289 €
- MBV Consult Retail sale of pharmaceutical products Lier · balance sheet 63,750 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Farma & Fit Retail sale of pharmaceutical products Rotselaar · balance sheet 71,427 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
Frequently asked questions about Liesap
What is the revenue of Liesap?
Liesap files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Liesap?
In Belgium, the VAT number is the company number prefixed with BE: BE0776459858 for Liesap, if the company is VAT-registered. Its company number (CBE) is 0776.459.858.
Where is the registered office of Liesap?
According to the CBE register, the registered office of Liesap is in 9260 Wichelen.
What is the equity of Liesap?
At the close of the 2025 financial year, the equity of Liesap amounts to 16,616 €, a solvency of 23.0% of total assets.
Who manages Liesap?
The register lists 1 active mandates at Liesap. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Liesap
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →